Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia

Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia

Abstract Background Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzymopathy worldwide. Primaquine is the only licensed drug that effectively removes Plasmodium vivax hypnozoites from the human host and prevents relapse. While well tolerated by most recipients, primaquine c...

Full description

Bibliographic Details
Main Authors: Gisela Henriques, Koukeo Phommasone, Rupam Tripura, Thomas J. Peto, Shristi Raut, Coco Snethlage, Im Sambo, Nou Sanann, Chea Nguon, Bipin Adhikari, Tiengkham Pongvongsa, Mallika Imwong, Lorenz von Seidlein, Nicholas P. Day, Nicholas J. White, Arjen M. Dondorp, Paul Newton, Benedikt Ley, Mayfong Mayxay
Format: Article
Language:English
Published: BMC 2018-06-01
Series:Malaria Journal
Subjects:
Malaria
Glucose-6-phosphate dehydrogenase
Rapid diagnostic test
Southeast Asia
Online Access:http://link.springer.com/article/10.1186/s12936-018-2390-6

Internet

http://link.springer.com/article/10.1186/s12936-018-2390-6

Similar Items